GH Research (GHRS) Current Leases (2023 - 2026)

GH Research (GHRS) posted quarterly Current Leases of $365000.0 for Q4 2025, up 43.14% year-over-year from $255000.0 in Q4 2024, and little changed quarter-over-quarter from $365000.0 in Q3 2025.

GH Research (GHRS) Current Leases (2023 - 2026) Analysis & Trends

GH Research's Current Leases history runs 3 years deep, the most recent figure standing at $365000.0 for Q4 2025.

  • In Q4 2025, Current Leases rose 43.14% year-over-year to $365000.0; the TTM figure through Dec 2025 stood at $365000.0 (up 43.14% YoY), while the FY2025 annual figure was $365000.0, up 43.14% from the prior year.
  • Current Leases for Q4 2025 stood at $365000.0, roughly flat from $365000.0 in the prior quarter.
  • The five-year high for Current Leases was $365000.0 in Q3 2025, with the low at $255000.0 in Q4 2024.
  • The 3-year median for Current Leases is $336000.0 (2024), against an average of $311727.3.
  • The sharpest annual moves came in 2024 and 2025: Current Leases retreated 25.66% in 2024, then soared 43.14% in 2025.
  • GH Research's Current Leases stood at $343000.0 in 2023, then declined by 25.66% to $255000.0 in 2024, then jumped by 43.14% to $365000.0 in 2025.
  • Business Quant data shows GHRS's Current Leases at $365000.0 in Q4 2025, $365000.0 in Q3 2025, and $364000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 11.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 16.75 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 21.95 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2.24 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 45.93 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 6.27 Mn
10 GH Research 2.02 Bn 1.68 Bn - 354,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 354,000.00
Dec 31, 2025 365,000.00
Sep 30, 2025 365,000.00
Jun 30, 2025 364,000.00
Mar 31, 2025 336,000.00
Dec 31, 2024 255,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 263,000.00
Mar 31, 2024 336,000.00
Dec 31, 2023 343,000.00
Sep 30, 2023 260,000.00
Jun 30, 2023 267,000.00